4.8 Article

The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection

期刊

BIOMATERIALS
卷 33, 期 12, 页码 3485-3493

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2012.01.030

关键词

Ocular; Intravitreal; Nanoparticle; Drug delivery; Vitreous; Retina

资金

  1. National Research Foundation of Korea (NRF)
  2. Ministry of Education, Science and Technology [2011-0009606]
  3. Graduate School of Specialization for Biotechnology of the Ministry of Knowledge Economy (MKE)
  4. Small & Medium Buisiness Administration [SD122946]
  5. MEST [2009-0081876]
  6. KIST
  7. National Research Foundation of Korea [2009-0081876, 2011-0009606] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

The purpose of this study is to determine the correlation between the distribution of nanoparticles in the vitreous and retina and their surface properties after intravitreal injection. For this purpose, we synthesized seven kinds of nanoparticles through self-assembly of amphiphilic polymer conjugates in aqueous condition. They showed similar size but different surface properties. They were labeled with fluorescent dyes for efficient tracking. After intravitreal injection of these nanoparticles into a rodent eye, their time-dependent distribution in the vitreous and retina was determined in stacking tissue images by confocal microscopy. The results demonstrated that the surface property of nanoparticles is a key factor in determining their distribution in the vitreous and retina after intravitreal injection. In addition, immunohistochemistry and TEM images of retina tissues suggested the important mechanism related with Muffler cells for intravitreally administered nanoparticles to overcome the physical barrier of inner limiting membrane and to penetrate into the deeper retinal structures. Therefore, we expect that this study can provide valuable information for biomedical researchers to develop optimized nanoparticles as drug or gene carriers for retinal and optic nerve disorders such as glaucoma, age-related macular degeneration, and diabetic retinopathy. (C) 2012 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据